276 related articles for article (PubMed ID: 11604353)
1. [Cellular therapy for intensification in oncology and hematology: manipulation of peripheral blood stem-cell products].
Douay L
Bull Cancer; 2001 Sep; 88(9):826-32. PubMed ID: 11604353
[TBL] [Abstract][Full Text] [Related]
2. [Methods of mobilizing hematopoietic cells, their collection using cell separation, purging--processing of pathologic cells and enrichment with CD 34+ cells--negative and positive selection].
Walter Z; Szostek M; Mensah P; Lorenz F; Weglarska D; Skotnicki AB
Przegl Lek; 1999; 56 Suppl 1():22-7. PubMed ID: 10494178
[TBL] [Abstract][Full Text] [Related]
3. Purging of peripheral blood progenitor cell autografts and treatment of minimal residual disease.
Brugger W; Scheding S; Bock T; Ziegler B; Kanz L
Stem Cells; 1997; 15 Suppl 1():159-65. PubMed ID: 9368336
[TBL] [Abstract][Full Text] [Related]
4. Ex vivo expansion of hematopoietic cells and their clinical use.
Aglietta M; Bertolini F; Carlo-Stella C; De Vincentiis A; Lanata L; Lemoli RM; Olivieri A; Siena S; Zanon P; Tura S
Haematologica; 1998 Sep; 83(9):824-48. PubMed ID: 9825579
[TBL] [Abstract][Full Text] [Related]
5. Ex vivo manipulation of hematopoietic stem cells for transplantation: the potential role of amifostine.
Balzarotti M; Grisanti S; Granzow K; Saladini A; Sala A; Nozza A; Molteni A; Passamonti F; Carlo-Stella C; Santoro A; Siena S
Semin Oncol; 1999 Apr; 26(2 Suppl 7):66-71. PubMed ID: 10348263
[TBL] [Abstract][Full Text] [Related]
6. Mobilized human CD34+ hematopoietic stem cells enhance tumor growth in a nonobese diabetic/severe combined immunodeficient mouse model of human non-Hodgkin's lymphoma.
de Bont ES; Guikema JE; Scherpen F; Meeuwsen T; Kamps WA; Vellenga E; Bos NA
Cancer Res; 2001 Oct; 61(20):7654-9. PubMed ID: 11606408
[TBL] [Abstract][Full Text] [Related]
7. Isolation of purified autologous peripheral blood CD34+ cells with low T cell content using CliniMACS device--a local experience.
Leong CF; Habsah A; Teh HS; Goh KY; Fadilah SA; Cheong SK
Malays J Pathol; 2008 Jun; 30(1):31-6. PubMed ID: 19108409
[TBL] [Abstract][Full Text] [Related]
8. Ex vivo manipulation of hematopoietic stem and progenitor cells.
Kanz L; Brugger W; Scheding S
Stem Cells; 1998; 16 Suppl 1():199-204. PubMed ID: 11012163
[TBL] [Abstract][Full Text] [Related]
9. Comparison of two different methods for CD34+ selection and T cell depletion in peripheral blood stem cell grafts--our experiences with CellPro, E rosetting and CliniMACS technique.
Poloucková A; Vodvárková A; Kobylka P; Hrubá A; Gasová Z; Marinov I; Fales I; Sedlácek P; Kozák T; Starý J
Neoplasma; 2001; 48(5):374-81. PubMed ID: 11845982
[TBL] [Abstract][Full Text] [Related]
10. The future of cell therapy.
Yee GC
Pharmacotherapy; 1996; 16(3 Pt 2):109S-115S. PubMed ID: 8726590
[TBL] [Abstract][Full Text] [Related]
11. Autologous bone marrow support and bone disease in metastatic breast cancer.
Nabholtz JM; al-Tweigeri T; Jacquelin N; Venner PM
Can J Oncol; 1995 Jul; 5(2):369-75. PubMed ID: 8853509
[TBL] [Abstract][Full Text] [Related]
12. [Stem cells in hematology and oncology].
Goldschmidt H; Egerer G; Fruehauf S; Ho AD
Med Klin (Munich); 2003 Dec; 98 Suppl 2():11-4. PubMed ID: 14992195
[TBL] [Abstract][Full Text] [Related]
13. Ex-vivo purging of hematopoietic progenitor cells.
de Lima M; Shpall EJ
Curr Hematol Rep; 2004 Jul; 3(4):257-64. PubMed ID: 15217555
[TBL] [Abstract][Full Text] [Related]
14. [High dose therapy with transplantation of autologous peripheral hematopoietic stem cells. I. Basic principles and clinical development].
Gunsilius E; Petzer A; Gastl G
Acta Med Austriaca; 1997; 24(3):97-101. PubMed ID: 9312975
[TBL] [Abstract][Full Text] [Related]
15. [Technical aspects of autologous bone marrow transplantation].
Handgretinger R; Klingebiel T; Niethammer D
Infusionsther Transfusionsmed; 1994 Nov; 21 Suppl 3():39-41. PubMed ID: 7841779
[TBL] [Abstract][Full Text] [Related]
16. [CD34+ cells in the autotransplant of bone marrow and peripheral blood].
Silvestri F; Baccarani M
Recenti Prog Med; 1992 Feb; 83(2):89-92. PubMed ID: 1380174
[TBL] [Abstract][Full Text] [Related]
17. Growth factors mobilize CXCR4 low/negative primitive hematopoietic stem/progenitor cells from the bone marrow of nonhuman primates.
Mahmud N; Patel H; Hoffman R
Biol Blood Marrow Transplant; 2004 Oct; 10(10):681-90. PubMed ID: 15389434
[TBL] [Abstract][Full Text] [Related]
18. CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients.
Kasow KA; Sims-Poston L; Eldridge P; Hale GA
Biol Blood Marrow Transplant; 2007 May; 13(5):608-14. PubMed ID: 17448921
[TBL] [Abstract][Full Text] [Related]
19. New strategies in the treatment of acute myelogenous leukemia: mobilization and transplantation of autologous peripheral blood stem cells in adult patients.
Bruserud O; Tjønnfjord G; Gjertsen BT; Foss B; Ernst P
Stem Cells; 2000; 18(5):343-51. PubMed ID: 11007918
[TBL] [Abstract][Full Text] [Related]
20. Human mesenchymal stem cells improve ex vivo expansion of adult human CD34+ peripheral blood progenitor cells and decrease their allostimulatory capacity.
Li N; Feugier P; Serrurrier B; Latger-Cannard V; Lesesve JF; Stoltz JF; Eljaafari A
Exp Hematol; 2007 Mar; 35(3):507-15. PubMed ID: 17309831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
